89 Zirconium labeled GSK-3128349

N/A

Report date: 2025/11/24 17:58:19

Base Information

Drug Name89 Zirconium labeled GSK-3128349

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Nuclides > Zirconium > 89ZrBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics +[6]

Mechanisms of ActionSerum albumin bindersPositron-emission tomography enhancers

TargetsSerum albumin

Therapy Area/IndicationsDrug-Related Side Effects and Adverse Reactions

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeN/A